# Ancilla W. Fernandes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ancilla-w-fernandes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,732 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 24 |
| i10-index | 43 |
| Last Known Institution | Pharmaceutical Product Development (United States) |
| OpenAlex ID | https://openalex.org/A5112284282 |
| Works | 88 |

## Researcher papers

Showing 12 of 16.

- [Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan](https://scholariq.org/papers/epidemiology-of-adult-idiopathic-inflammatory-myopathies-in-a-u-s-managed-care/)
- [Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children](https://scholariq.org/papers/fatality-rates-in-published-reports-of-rsv-hospitalizations-among-high-risk-and/)
- [Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis](https://scholariq.org/papers/incidence-and-prevalence-of-idiopathic-inflammatory-myopathies-among/)
- [A structured literature review of the direct costs of adult systemic lupus erythematosus in the US](https://scholariq.org/papers/a-structured-literature-review-of-the-direct-costs-of-adult-systemic-lupus/)
- [Adolescent nicotine dependence and smoking cessation outcomes](https://scholariq.org/papers/adolescent-nicotine-dependence-and-smoking-cessation-outcomes/)
- [A 2-Year Efficacy Study of Not On Tobacco in Florida: An Overview of Program Successes in Changing Teen Smoking Behavior](https://scholariq.org/papers/a-2-year-efficacy-study-of-not-on-tobacco-in-florida-an-overview-of-program/)
- [Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: A systematic literature review and meta-analysis](https://scholariq.org/papers/mortality-and-morbidity-among-infants-at-high-risk-for-severe-respiratory/)
- [Epidemiology of Systemic Sclerosis in a Large US Managed Care Population](https://scholariq.org/papers/epidemiology-of-systemic-sclerosis-in-a-large-us-managed-care-population/)
- [Statewide Demonstration of Not On Tobacco: A Gender-Sensitive Teen Smoking Cessation Program](https://scholariq.org/papers/statewide-demonstration-of-not-on-tobacco-a-gender-sensitive-teen-smoking/)
- [Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured Population](https://scholariq.org/papers/annual-medical-costs-and-healthcare-resource-use-in-patients-with-systemic/)
- [CKD progression, kidney failure, and mortality among US patients with IgA nephropathy](https://scholariq.org/papers/ckd-progression-kidney-failure-and-mortality-among-us-patients-with-iga/)
- [Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021](https://scholariq.org/papers/incidence-and-proportion-of-primary-focal-segmental-glomerulosclerosis-fsgs/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [Pharmaceutical Product Development (United States)](https://scholariq.org/institutions/pharmaceutical-product-development-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.